ArticleFrontiers in oncology2021

Identification of PAFAH1B3 as Candidate Prognosis Marker and Potential Therapeutic Target for Hepatocellular Carcinoma.

Weikang Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.